Abstract:Objective Inferring cancer driver genes, especially rare or sample-specific cancer driver genes, is crucial for precision oncology. Considering the high inter-tumor heterogeneity, a few recent methods attempt to reveal cancer driver genes at the individual level. However, most of these methods generally integrate multi-omics data into a single biomolecular network (e.g., gene regulatory network or protein-protein interaction network) to identify cancer driver genes, which results in missing important interactions highlighted in different networks. Thus, the development of a multiplex network method is imperative in order to integrate the interactions of different biomolecular networks and facilitate the identification of cancer driver genes.Methods A multiplex network control method called Personalized cancer Driver Genes with Multiplex biomolecular Networks (PDGMN) was proposed. Firstly, the sample-specific multiplex network, which contains protein-protein interaction layer and gene-gene association layer, was constructed based on gene expression data. Subsequently, somatic mutation data was integrated to weight the nodes in the sample-specific multiplex network. Finally, a weighted minimum vertex cover set identification algorithm was designed to find the optimal set of driver nodes, facilitating the identification of personalized cancer driver genes.Results The results derived from three TCGA cancer datasets indicate that PDGMN outperforms other existing methods in identifying personalized cancer driver genes, and it can effectively identify the rare driver genes in individual patients. Particularly, the experimental results indicate that PDGMN can capture the unique characteristics of different biomolecular networks to improve cancer driver gene identification.Conclusion PDGMN can effectively identify personalized cancer driver genes and broaden our understanding of cancer driver gene identification from a multiplex network perspective. The source code and datasets used in this work are available at https://github.com/NWPU-903PR/PDGMN.

Construction and Analysis of Sample-Specific Driver Modules for Breast Cancer

An Integrated Approach to Uncover Driver Genes in Breast Cancer Methylation Genomes

Identifying Cancer Specific Driver Modules Using A Network-Based Method

Cancer Core Modules Identification Through Genomic and Transcriptomic Changes Correlation Detection at Network Level.

The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.

Identifying Driver Genes of Breast Cancer by Integrated Analysis of Methylation and Expression Data in Paired Disease-Normal Samples of Patients

DriverML: a Machine Learning Algorithm for Identifying Driver Genes in Cancer Sequencing Studies

Identification of Collaborative Driver Pathways in Breast Cancer

PhenoDriver: Interpretable Framework for Studying Personalized Phenotype-Associated Driver Genes in Breast Cancer

Discovering personalized driver mutation profiles of single samples in cancer by network control strategy.

A Multiplex Network Control Method for Identifying Personalized Cancer Driver Genes

Personalized analysis of breast cancer using sample-specific networks

Uncovering driver genes in breast cancer through an innovative machine learning mutational analysis method

Identification of Driver Network Modules in Protein-Protein Interaction Network Using Patient Mutation Profiles

Identification of Cancer Driver Modules by Combining Network Functional and Topology Information.

DriverMP enables improved identification of cancer driver genes

Advancing cancer driver gene identification through an integrative network and pathway approach

Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.

Cooperative Driver Module Identification Based on Single Cell Data

Identifying Cancer Patient Subgroups by Finding Co-Modules from the Driver Mutation Profiles and Downstream Gene Expression Profiles

Identifying Driver Genes Involving Gene Dysregulated Expression, Tissue-Specific Expression and Gene-Gene Network